Vector Immunology Core
Vector Immunology Core
批准号:
10463804
负责人:
Guangping Gao
金额:
$33.5万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-09 至 2026-07-31
关键词:
AntibodiesAntigensB-LymphocytesBindingBiological AssayCapsidCell TherapyCellsClinicClinical TrialsClustered Regularly Interspaced Short Palindromic RepeatsCystic FibrosisDataDiseaseDisease modelDoseEngineeringEnzyme-Linked Immunosorbent AssayEvaluationFerretsFlow CytometryGene DeliveryGene Transduction AgentGoalsGrantHumanHumoral ImmunitiesImmuneImmune responseImmune systemImmunityImmunological ModelsImmunologyImmunology procedureMeasuresMediatingModelingMonkeysMusNeutralizing antibody assayOutcomePatientsProgram Research Project GrantsProteinsProtocols documentationReagentRegulatory T-LymphocyteResourcesRespiratory Tract InfectionsRoleSerious Adverse EventSerologyStainsStandardizationSteroidsT cell responseT-LymphocyteTestingTherapeuticTransgenesVirusadeno-associated viral vectoralpha 1-Antitrypsin Deficiencybasecell mediated immune responseclinically relevantcytokinecytotoxicdisease phenotypeenzyme linked immunospot assaygene therapyimmunogenicmouse modelnovelresponsetherapeutic genetransgene expressionvector
中文摘要
核心A -总结/摘要:
Vector Immunology Core将直接支持该计划项目的所有四个项目
通过提供可靠的、一致的和标准化的免疫学检测来获得资助。将重点
创建、验证和执行免疫学测定,以表征B细胞和T细胞
在小鼠和雪貂中对AAV的免疫应答。它还将检测布斯的免疫反应,
衣壳和转基因产物。核心将通过表征B细胞来支持所有四个项目
通过基于转导抑制的NAB测定和ELISA测定衣壳结合的应答
抗体和抗转基因抗体。它将开发和标准化检测方法,
雪貂B细胞反应它还将通过ELISPOT表征T细胞应答,
通过ELISA和基于流动的细胞因子珠测定进行细胞因子谱分析。最后将
开发用于评估雪貂免疫应答的流式细胞术染色方案,
目前还没有得到很好的表征。总的来说,免疫学核心将提供有价值的数据,
支持和资源的所有四个项目在这个计划项目赠款,这将允许
更好地理解免疫系统在基因和细胞治疗中的作用。
英文摘要
CORE A - SUMMARY/ABSTRACT:
The Vector Immunology Core will directly support all four projects of this program project
grant by providing reliable, consistent and standardized immunological assays. It will focus on
creating, validating and performing immunological assays to characterize B-cell and T-cell
immune responses to AAV, in mice and ferrets. It will also assay booth immune responses to
capsid and to transgene product. The core will support all four projects by characterizing B-cell
responses by transduction inhibition based NAB assays and ELISAs for capsid binding
antibodies and anti-transgene antibodies. It will develop and standardize assays for evaluating
ferret B-cell responses. It will additionally characterize T-cell responses by ELISPOT, and
cytokine profiling through both ELISA and flow-based cytokine bead assays. Finally, it will
develop flow cytometry staining protocols for the evaluation of Ferret immune responses, which
are currently not well characterized. Overall the immunology core will provide valuable data,
support and resources to all four projects within this program project grant, which will allow for
better understanding of the role the immune system in gene and cell therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vector Immunology Core
-
批准号:10270090
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2021
-
负责人:Guangping Gao
-
依托单位:
Vector Immunology Core
-
批准号:10674936
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2021
-
负责人:Guangping Gao
-
依托单位:
Core C: Viral vector core
-
批准号:10381476
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2020
-
负责人:Guangping Gao
-
依托单位:
Core C: Viral vector core
-
批准号:10625277
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2020
-
负责人:Guangping Gao
-
依托单位:
Novel gene therapy strategies for Canavan disease
-
批准号:8731279
-
项目类别:
-
资助金额:$46.8万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Minimizing transgene clearance
-
批准号:8311212
-
项目类别:
-
资助金额:$53.9万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
AAV Core
-
批准号:8311218
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Novel gene therapy strategies for Canavan disease
-
批准号:8536397
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Novel gene therapy strategies for Canavan disease
-
批准号:8440014
-
项目类别:
-
资助金额:$50.28万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Novel Gene Therapy Strategies for Canavan Disease
-
批准号:10561698
-
项目类别:
-
资助金额:$42.24万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Novel Gene Therapy Strategies for Canavan Disease
-
批准号:10338159
-
项目类别:
-
资助金额:$42.24万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Novel Gene Therapy Strategies for Canavan Disease
-
批准号:9912190
-
项目类别:
-
资助金额:$45.93万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Safety and efficacy of optimized AAV3 vectors in murine and NHP livers
-
批准号:8536287
-
项目类别:
-
资助金额:$28.3万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Novel gene therapy strategies for Canavan disease
-
批准号:9145787
-
项目类别:
-
资助金额:$47.27万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Safety and efficacy of optimized AAV3 vectors in murine and NHP livers
-
批准号:8359305
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Next Generation of Recombinant AAV Serotype For Gene Therapy
-
批准号:9197791
-
项目类别:
-
资助金额:$14.25万
-
财政年份:2010
-
负责人:Guangping Gao
-
依托单位:
MOLECULAR BIOLOGY OF AAV IN LIVER
-
批准号:8147963
-
项目类别:
-
资助金额:$48.01万
-
财政年份:2010
-
负责人:Guangping Gao
-
依托单位:
Next Generation of Recombinant AAV Serotype For Gene Therapy
-
批准号:9252509
-
项目类别:
-
资助金额:$78.86万
-
财政年份:2010
-
负责人:Guangping Gao
-
依托单位:
Next Generation of Recombinant AAV Serotype For Gene Therapy
-
批准号:9057118
-
项目类别:
-
资助金额:$62.22万
-
财政年份:2010
-
负责人:Guangping Gao
-
依托单位:
Molecular Biology of AAV in Liver
-
批准号:7595330
-
项目类别:
-
资助金额:$42.71万
-
财政年份:2009
-
负责人:Guangping Gao
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: